Skip to main content
. 2023 Jun 7;11(6):e006802. doi: 10.1136/jitc-2023-006802

Figure 1.

Figure 1

High monocytic myeloid-derived suppressor cell frequencies before start of immune checkpoint blockade correlate significantly with shorter overall and progression-free survival in the discovery (A: p=0.030 and C: p=0.001) and validation cohort (B: p<0.001 and D: p=0.007).